Abstract |
Geraniol (GOH), a natural component of plant essential oils, exhibits potent antioxidant and anti-inflammatory properties. The aim of this study was to assess the protective effects and mechanisms of GOH on lipopolysaccharide (LPS)/d- galactosamine (D-GalN)-induced fulminant hepatic failure (FHF). Mice were treated with GOH (12.5, 25, and 50 μg/kg) 1 h before challenging LPS (60 mg/kg) and D-GalN (800 mg/kg). 8 h later LPS/D-GlaN treatment, mice were sacrificed and the serum and the liver tissues were collected for testing. The liver pathological changes were assessed by H & E staining. MPO activity, MDA level in liver tissues, and AST, ALT levels in serum were detected by specific detection kits. The levels of TNF-α and IL-1β were detected by ELISA. The expression of NF-κB and PPARγ were detected by western blot analysis and qRT-PCR. The results showed that GOH had a protective effect on LPS/D-GalN-induced FHF, as evidence by the attenuation of liver pathological injury, MPO activity, MDA level, and serum AST and ALT levels. GOH reduced liver TNF-α and IL-1β levels through inhibiting NF-κB signaling pathway activation. Furthermore, GOH increased PPARγ expression in FHF induced by LPS/D-GalN. In conclusion, the present study proved that GOH protects against LPS/D-GalN-induced FHF through inhibiting inflammatory response and increasing PPARγ expression.
|
Authors | Yi Li, Nian Wang, Yongfang Jiang |
Journal | Microbial pathogenesis
(Microb Pathog)
Vol. 128
Pg. 7-12
(Mar 2019)
ISSN: 1096-1208 [Electronic] England |
PMID | 30550845
(Publication Type: Journal Article)
|
Copyright | Copyright © 2018. Published by Elsevier Ltd. |
Chemical References |
- Acyclic Monoterpenes
- Anti-Inflammatory Agents
- Antioxidants
- Interleukin-1beta
- Lipopolysaccharides
- NF-kappa B
- Oils, Volatile
- PPAR gamma
- Plant Oils
- Protective Agents
- Terpenes
- Tumor Necrosis Factor-alpha
- Galactosamine
- geraniol
|
Topics |
- Acyclic Monoterpenes
- Animals
- Anti-Inflammatory Agents
(pharmacology)
- Antioxidants
(pharmacology)
- Disease Models, Animal
- Galactosamine
(adverse effects)
- Interleukin-1beta
(metabolism)
- Lipopolysaccharides
(adverse effects)
- Liver
(chemistry, injuries, pathology)
- Liver Failure, Acute
(drug therapy)
- Male
- Mice
- Mice, Inbred C57BL
- NF-kappa B
(metabolism)
- Oils, Volatile
(pharmacology)
- PPAR gamma
(metabolism)
- Plant Oils
(pharmacology)
- Protective Agents
(pharmacology)
- Signal Transduction
(drug effects)
- Terpenes
(administration & dosage, pharmacology)
- Tumor Necrosis Factor-alpha
(metabolism)
|